Page 17 - 南京医科大学学报自然科学版
P. 17

第44卷第1期          肖心儒,范     亮,施宇佳,等. A2M在慢性阻塞性肺疾病中的表达及其与免疫细胞浸润的
                  2024年1月               相关性[J]. 南京医科大学学报(自然科学版),2024,44(01):001-011,059                 · 11  ·


                    2244-2253                                    [16] CRUZ T,LÓPEZ⁃GIRALDO A,NOELL G,et al. Multi⁃
               [4] FERMONT J M,MASCONI K L,JENSEN M T,et al. Bio⁃      level immune response network in mild⁃moderate chronic
                    markers and clinical outcomes in COPD:a systematic re⁃  obstructive pulmonary disease(COPD)[J]. Respir Res,
                    view and meta⁃analysis[J]. Thorax,2019,74(5):439-  2019,20(1):1-9
                    446                                          [17]WORRELL J C,MACLEOD M K. Stromal ⁃immune cell
               [5] MENG H,LONG Q,WANG R,et al. Identification of the  crosstalk fundamentally alters the lung microenvironment
                    key immune⁃related genes in chronic obstructive pulmo⁃  following tissue insult[J]. Immunology,2021,163(3):
                    nary disease based on immune infiltration analysis[J].  239-249
                    Int J Chron Obstruct Pulmon Dis,2022,17:13-24  [18] 丁  明,袁  成,李    萍,等. 稳定期慢性阻塞性肺疾病
               [6] ZHANG Y,XIA R,LV M,et al. Machine⁃learning algo⁃    患者肺泡灌洗液中 IL⁃8、IL⁃17 水平的相关性研究[J].
                    rithm⁃based prediction of diagnostic gene biomarkers re⁃  南京医科大学学报(自然科学版),2019,39(6):884-
                    lated to immune infiltration in patients with chronic ob⁃  889
                    structive pulmonary disease[J]. Front Immunol,2022,  [19] BELCHAMBER K B,DONNELLY L E. Targeting defec⁃
                    13:740513                                          tive pulmonary innate immunity⁃a new therapeutic option?
               [7] YANG Y C,ZHANG M Y,LIU J Y,et al. Identification of  [J]. Pharmacol Ther,2020,209:107500
                    ferroptosis ⁃ related hub genes and their association with  [20] BARCZYK A,PIERZCHALA W,KON O M,et al. Cyto⁃
                    immune infiltration in chronic obstructive pulmonary dis⁃  kine production by bronchoalveolar lavage T lymphocytes
                    ease by bioinformatics analysis[J]. Int J Chron Obstruct  in chronic obstructive pulmonary disease[J]. J Allergy
                    Pulmon Dis,2022,17:1219-1236                       Clin Immunol,2006,117(6):1484-1492
               [8] XIAO X,CAI W,DING Z,et al. LincRNA00612 inhibits  [21] KAPELLOS T S,BONAGURO L,GEMÜND I,et al. Hu⁃
                    apoptosis and inflammation in LPS ⁃ induced BEAS ⁃ 2B  man monocyte subsets and phenotypes in major chronic
                    cells via enhancing interaction between p ⁃ STAT3 and  inflammatory diseases[J]. Front Immunol,2019,10:2035
                    A2M promoter[J]. Peer J,2023,11:e14986       [22] KNOBLOCH J,PANEK S,YANIK S D,et al. The mono⁃
               [9] XIAO X,CAI W,DING Z,et al. A2M serves as promising  cyte ⁃ dependent immune response to bacteria is sup⁃
                    biomarker for chronic obstructive pulmonary disease[J].  pressed in smoking⁃induced COPD[J]. J Mol Med,2019,
                    Int J Chron Obstruct Pulmon Dis,2023,18:683-692    97(6):817-828
               [10] VANDOOREN J,ITOH Y. Alpha⁃2⁃macroglobulin in in⁃  [23] SUZUKI M,SZE M A,CAMPBELL J D,et al. The cellu⁃
                    flammation,immunity and infections[J]. Front Immunol,  lar and molecular determinants of emphysematous de⁃
                    2021,12:803244                                     struction in COPD[J]. Sci Rep,2017,7(1):9562
               [11]CUÉLLAR J M,CUÉLLAR V G,SCUDERI G J. α2⁃Mac⁃  [24] FINCH D K,STOLBERG V R,FERGUSON J,et al. Lung
                    roglobulin:autologous protease inhibition technology[J].  dendritic cells drive natural killer cytotoxicity in chronic
                    Phys Med Rehabil Clin N Am,2016,27(4):909-918      obstructive pulmonary disease via IL ⁃ 15Rα[J]. Am J
               [12] Global Initiative for Chronic Obstructive Lung Disease.  Respir Crit Care Med,2018,198(9):1140-1150
                    Global strategy for the prevention and diagnosis,manage⁃  [25] PERROT G,LANGLOIS B,DEVY J,et al. LRP⁃1⁃CD44,
                    ment of chronic obstructive pulmonary disease 2022 re⁃  a new cell surface complex regulating tumor cell adhesion
                    port[R/OL].(2021⁃11⁃22)[2021⁃11⁃15]. https://gold⁃  [J]. Mol Cell Biol,2012,32(16):3293-3307
                    copd.org/gold⁃reports.html                   [26] GOPAL U,GONZALEZ⁃GRONOW M,PIZZO S V. Acti⁃
               [13] GRAHAM B L,STEENBRUGGEN I,MILLER M R,et al.        vated α2⁃macroglobulin regulates transcriptional activa⁃
                    Standardization of spirometry 2019 update. An official  tion of c⁃MYC target genes through cell surface GRP78
                    American thoracic society and European respiratory soci⁃  protein[J]. J Biol Chem,2016,291(20):10904-10915
                    ety technical statement[J]. Am J Respir Crit Care Med,  [27] ARANDJELOVIC S,FREED T A,GONIAS S L. Growth
                    2019,200(8):e70-e88                                factor ⁃ binding sequence in human α2 ⁃ macroglobulin
               [14] BU T,WANG L F,YIN Y Q. How do innate immune cells  targets the receptor ⁃ binding site in transforming growth
                    contribute to airway remodeling in COPD progression?  factor⁃β[J]. Biochemistry,2003,42(20):6121-6127
                    [J]. Int J Chron Obstruct Pulmon Dis,2020,15:107-116  [28] POLLER W,BARTH J,VOSS B. Detection of an altera⁃
               [15] CARAMORI G,RUGGERI P,DI STEFANO A,et al. Au⁃       tion of the α2 gene in a patient with chronic lung disease
                    toimmunity and COPD:clinical implications[J]. Chest,  and serum α2 deficiency[J]. Hum Genet,1989,83(1):
                    2018,153(6):1424-1431                              93-96                      (下转第59页)
   12   13   14   15   16   17   18   19   20   21   22